tiprankstipranks
Advertisement
Advertisement
Harmony Biosciences reaffirms FY26 net product revenue guidance $1B-$1.04B
PremiumThe FlyHarmony Biosciences reaffirms FY26 net product revenue guidance $1B-$1.04B
17d ago
Harmony Biosciences announces departure of CFO Reicin
Premium
The Fly
Harmony Biosciences announces departure of CFO Reicin
17d ago
Harmony Biosciences price target raised to $36 from $30 at Deutsche Bank
Premium
The Fly
Harmony Biosciences price target raised to $36 from $30 at Deutsche Bank
1M ago
Harmony Biosciences reports Q1 EPS 55c, consensus 93c
PremiumThe FlyHarmony Biosciences reports Q1 EPS 55c, consensus 93c
3M ago
Harmony Biosciences backs FY26 revenue view $1B-$1.04B, consensus $1.02B
Premium
The Fly
Harmony Biosciences backs FY26 revenue view $1B-$1.04B, consensus $1.02B
3M ago
H.C. Wainwright views weakness in Harmony shares as ‘excessive IP overhang’
Premium
The Fly
H.C. Wainwright views weakness in Harmony shares as ‘excessive IP overhang’
3M ago
Harmony Biosciences Names New CFO to Drive Growth
PremiumCompany AnnouncementsHarmony Biosciences Names New CFO to Drive Growth
4M ago
Harmony Biosciences appoints Reicin as Chief Financial Officer
Premium
The Fly
Harmony Biosciences appoints Reicin as Chief Financial Officer
4M ago
Harmony Biosciences reiterates FY26 net product revenue view of $1B-$1.04B
Premium
The Fly
Harmony Biosciences reiterates FY26 net product revenue view of $1B-$1.04B
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100